Prosecution Insights
Last updated: October 04, 2026

Merck Millipore Ltd.

Technology area: Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Merck Millipore Ltd. currently has 2 pending office actions within the Chemistry & Materials technology area. The prosecution is divided between 2 distinct examiners and 2 distinct art units, which points to a broader technical range for the pending applications. HUANG, RYAN is the busiest examiner in the portfolio, currently responsible for 1 busiest examiner pending action. This means the 2 total pending office actions are split among the examiners involved.

The involvement of 2 distinct art units requires the applicant to adapt to different examination cultures and prior art landscapes. Since HUANG, RYAN handles 1 busiest examiner pending action, the other pending matter is being processed by a different examiner in a separate unit. This distribution across 2 distinct examiners suggests that the company is pursuing diverse innovations within the chemistry sector. Managing 2 pending office actions in this manner necessitates a tailored approach for each of the 2 distinct art units to ensure successful prosecution outcomes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HUANG, RYAN 1 52.9% +31.1%
LACLAIR, LOGAN EDWARD 1 78.2% +22.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17779054 METHODS FOR COUPLING A LIGAND TO A COMPOSITE MATERIAL HUANG, RYAN —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17642322 SUPERCRITICAL DRYING OF CHROMATOGRAPHIC MEDIA LACLAIR, LOGAN EDWARD 15d
17779054 METHODS FOR COUPLING A LIGAND TO A COMPOSITE MATERIAL HUANG, RYAN —

Top Art Units

Art UnitApps
1777 1
1736 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17779054 METHODS FOR COUPLING A LIGAND TO A COMPOSITE MATERIAL HUANG, RYAN 1777 §102§103§112 Non-Final OA — Pending May 23, 2022
17642322 SUPERCRITICAL DRYING OF CHROMATOGRAPHIC MEDIA LACLAIR, LOGAN EDWARD 1736 §103 Final Rejection 15d Pending Mar 11, 2022

Managing Merck Millipore Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month